← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-02-10
Drug application
- FDA Application #
ANDA207325- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXALIPLATIN
- Generic name
- OXALIPLATIN
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- GLAND
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- First approval
- 2017-02-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown